Meri Utriainen U.
- Country
- Finland
- Department
- #1401:Comprehensive cancer centre
Research Overview
Data & Insights
Has run more than one trial at 0 of 85 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in the treatment of hormone receptor-positive, HER2-negative advanced breast cancer, focusing on innovative therapeutic approaches for patients who have undergone prior treatments.
- Advanced Breast Cancer Management
- Hormone Receptor-Positive Disease
- Treatment-Resistant Cases
Clinical interests include combination therapy strategies utilizing endocrine therapy with targeted agents for breast cancer treatment.
Endocrine Therapy
Research expertise centers on therapeutic combinations involving fulvestrant and investigating novel treatment pathways for hormone-dependent breast cancers.
- Endocrine Resistance
- Sequential Therapy
- Treatment Optimization
Particular focus on developing solutions for patients who have progressed after receiving CDK4/6 inhibitor therapy.
Targeted Therapies
Investigates novel targeted therapeutic approaches for advanced breast cancer, with particular expertise in treatments following progression on standard therapies.
- Treatment Sequencing
- Drug Resistance
- Therapeutic Innovation
Explores the potential of combination treatment strategies to improve patient outcomes in advanced disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.